Compassionate Use of Hyperbaric Oxygen Therapy

SerenaGroup, Inc.100 enrolled

Overview

This is an observational patient registry of COVID-19 patients treated with HBOT.

The retrospective analysis will focus on the reduction in need for mechanical ventilation in COVID-19 patients. The information will be gathered prospectively. Data will be collected from the patients' medical record, including medical notes and data recorded into the study database.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

COVID-19

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patients with COVID-19. * The clinical decision to use HBOT is independent of the decision to participate in registry. * A signed and dated informed consent form for the off-label use of Hyperbaric Oxygen Therapy specific to the institution where treatment is rendered. * Subject is willing and able to comply with instructions and scheduled visits. Exclusion Criteria: * The Subject has other concurrent conditions that in the opinion of the Investigator may compromise patient safety. * The patient has an untreated pneumothorax.

Locations (11)

White River Wound Healing Center

Batesville, Arkansas, United States

Community Hospital

Monterey, California, United States

Innovative Healing Systems

Tampa, Florida, United States

Outcomes

Primary Outcomes

Gather information on patients treated with hyperbaric oxygen therapy

Collect information on the reduction in need for mechanical ventilation in COVID-19 patients.

Time frame: 24 months

Secondary Outcomes

Gather information on adverse events

Follow adverse events associated with the treatment of COVID-19 related to HBOT

Time frame: 24 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.